In today’s session Adeptus Health Inc (ADPT) recorded an unusually high (610) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the November, 2016 put, expecting serious ADPT decrease. With 610 contracts traded and 2154 open interest for the Nov, 16 contract, it seems this is a quite bearish bet. The option with symbol: ADPT161118P00045000 closed last at: $6.8 or 17.2% up. About 76,426 shares traded hands. Adeptus Health Inc (NYSE:ADPT) has declined 30.88% since March 2, 2016 and is downtrending. It has underperformed by 39.14% the S&P500.
Analysts await Adeptus Health Inc (NYSE:ADPT) to report earnings on October, 27. They expect $0.48 earnings per share, up 77.78% or $0.21 from last year’s $0.27 per share. ADPT’s profit will be $9.98M for 21.72 P/E if the $0.48 EPS becomes a reality. After $0.43 actual earnings per share reported by Adeptus Health Inc for the previous quarter, Wall Street now forecasts 11.63% EPS growth.
Adeptus Health Inc (NYSE:ADPT) Ratings Coverage
Out of 5 analysts covering Adeptus Health (NYSE:ADPT), 5 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $135 is the highest target while $62 is the lowest. The $95.33 average target is 128.61% above today’s ($41.7) stock price. Adeptus Health has been the topic of 11 analyst reports since August 3, 2015 according to StockzIntelligence Inc. KeyBanc Capital Markets maintained Adeptus Health Inc (NYSE:ADPT) rating on Friday, September 18. KeyBanc Capital Markets has “Overweight” rating and $129 price target. The stock of Adeptus Health Inc (NYSE:ADPT) earned “Buy” rating by Jefferies on Monday, July 11. Dougherty & Company maintained the stock with “Buy” rating in Wednesday, November 18 report. The rating was maintained by Piper Jaffray on Thursday, August 13 with “Overweight”. On Friday, July 24 the stock rating was maintained by RBC Capital Markets with “Outperform”. Jefferies initiated it with “Buy” rating and $135 target price in Monday, August 3 report. JMP Securities maintained Adeptus Health Inc (NYSE:ADPT) rating on Wednesday, August 31. JMP Securities has “Market Outperform” rating and $92 price target. RBC Capital Markets maintained the shares of ADPT in a report on Friday, October 23 with “Outperform” rating.
According to Zacks Investment Research, “Adeptus Health, Inc. owns and operates First Choice Emergency Room, the network of independent freestanding emergency rooms in the United States. The Company provides emergency medical care to patients in Texas and Colorado. It has developed a facility design and infrastructure specifically tailored to the emergency care delivery system that combines staff, equipment and physical layout to deliver care. Adeptus Health Inc. is based in Lewisville, Texas.”
Insitutional Activity: The institutional sentiment increased to 1.96 in Q2 2016. Its up 0.04, from 1.92 in 2016Q1. The ratio increased, as 29 funds sold all Adeptus Health Inc shares owned while 25 reduced positions. 22 funds bought stakes while 84 increased positions. They now own 21.33 million shares or 18.77% more from 17.95 million shares in 2016Q1.
Coe Cap Mngmt Ltd holds 17,825 shares or 0% of its portfolio. Tpg accumulated 1.47M shares or 10.94% of the stock. Victory Capital Inc, a Ohio-based fund reported 1,184 shares. Creative Planning accumulated 230 shares or 0% of the stock. Scout Invests Inc reported 28,475 shares or 0.04% of all its holdings. Wells Fargo & Mn last reported 641,914 shares in the company. Advisors Asset Mgmt has 0.01% invested in the company for 17,522 shares. Deerfield Mgmt Communications holds 3.25% or 1.60 million shares in its portfolio. Ls Invest Advsrs Ltd Llc has invested 0% of its portfolio in Adeptus Health Inc (NYSE:ADPT). Blackrock Lc has invested 0% of its portfolio in Adeptus Health Inc (NYSE:ADPT). Teachers Retirement Systems Of The State Of Kentucky has 4,300 shares for 0% of their US portfolio. Macquarie Group Incorporated has 100,032 shares for 0.01% of their US portfolio. Marshall Wace Ltd Liability Partnership accumulated 0.02% or 41,447 shares. Franklin Resource Incorporated last reported 880,165 shares in the company. Glenmede Na, a Pennsylvania-based fund reported 700 shares.
Adeptus Health Inc. is a patient-centered healthcare company. The company has a market cap of $866.70 million. The Firm is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. It has a 6.67 P/E ratio. The Firm has approximately 80 freestanding facilities and over two licensed general hospitals.
ADPT Company Profile
Adeptus Health Inc., incorporated on March 7, 2014, is a patient-centered healthcare company. The Firm is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Firm has approximately 80 freestanding facilities and over two licensed general hospitals. The Firm owns or operates facilities located in the Houston, Dallas/Fort Worth, San Antonio and Austin, Texas markets; Colorado Springs and Denver, Colorado markets, and Phoenix, Arizona market.
More notable recent Adeptus Health Inc (NYSE:ADPT) news were published by: Prnewswire.com which released: “Adeptus Health Inc. Appoints Frank R. Williams, Jr. as Chief Financial Officer” on July 28, 2016, also Prnewswire.com with their article: “Adeptus Health Inc. to Present at the Morgan Stanley Global Healthcare Conference” published on September 06, 2016, Prnewswire.com published: “Adeptus Health Inc. Announces Closing of $175 Million Senior Secured Credit …” on October 07, 2015. More interesting news about Adeptus Health Inc (NYSE:ADPT) were released by: Prnewswire.com and their article: “Adeptus Health Inc. Appoints Dr. Ricardo Martinez as Chief Medical Officer” published on June 24, 2016 as well as Prnewswire.com‘s news article titled: “Adeptus Health Inc. Announces Pricing of Common Stock Offering” with publication date: June 03, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.